Home » Topics » Regulatory » Patents

Patents
RSS

Santen presents new LTA4 hydrolase inhibitors

June 15, 1998

Potent squalene synthase inhibitors as cholesterol-lowering agents

June 12, 1998

Japanese companies team up to develop compounds for schizophrenia

June 12, 1998

Preparation and use of new MMP inhibitors from Warner-Lambert

June 12, 1998

Asahi Glass, Santen develop ophthalmic agents with good safety

June 12, 1998

Procter & Gamble reveals new series of metalloprotease inhibitors

June 12, 1998

Neuroprotective agents based on enzyme inhibition prepared at P&U

June 11, 1998

Pfizer team reveals heterobicyclic CRF antagonists

June 11, 1998

Novel rapamycin derivatives patented by AHP

June 11, 1998

Warner-Lambert team describes preferential inhibitors of MMP-2 and MMP-3

June 11, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...